Rotavirus strains belonging to G types 1 to 4 and having a P3 genotype (M37-1ike VP4) were recovered from children with symptomatic and asymptomatic infections. Partial sequences of their VP4 genes were determined in an attempt to characterize these strains further. The genomic regions encoding VP8*, the connecting and putative fusion peptides and three other regions in VP5* were sequenced. The deduced amino acid sequences were compared with rotavirus strains belonging to different P genotypes that had been previously reported. High degrees of identity were found between the VP8* fragment of all human P3 strains (92"7 to 99-7%) suggesting that they belong to the same genotype, regardless of differences in their virulence. Furthermore, based on comparative sequence analysis, we did not identify any amino acid(s) that differ appreciably between symptomatic and asymptomatic strains and could therefore be associated with virulence. The results suggest that the P3 genotype, although frequently associated with asymptomatic infections, may not be the single determining factor in attenuation of symptoms.
Rotavirus strains belonging to G types 1 to 4 and having a P3 genotype (M37-1ike VP4) were recovered from children with symptomatic and asymptomatic infections. Partial sequences of their VP4 genes were determined in an attempt to characterize these strains further. The genomic regions encoding VP8*, the connecting and putative fusion peptides and three other regions in VP5* were sequenced. The deduced amino acid sequences were compared with rotavirus strains belonging to different P genotypes that had been previously reported. High degrees of identity were found between the VP8* fragment of all human P3 strains (92"7 to 99-7%) suggesting that they belong to the same genotype, regardless of differences in their virulence. Furthermore, based on comparative sequence analysis, we did not identify any amino acid(s) that differ appreciably between symptomatic and asymptomatic strains and could therefore be associated with virulence. The results suggest that the P3 genotype, although frequently associated with asymptomatic infections, may not be the single determining factor in attenuation of symptoms.
Neonatal rotavirus infection in children is rarely associated with symptoms (Chrystie et al., 1978; Rodger et al., 1981 ; Perez-Schael et al., 1984) . Nevertheless, it seems to confer protection against subsequent severe rotavirus diarrhoea (Bishop et al., 1983) . Strains recovered from neonates with asymptomatic infections differed from the strain of the rotavirus causing symptomatic infection and may be naturally attenuated (Flores et al., 1986; Gorziglia et al., 1988) . Thus, they are suitable candidates for vaccines. Attempts to develop a vaccine using the asymptomatic strain M37 are currently underway Midthun et al., 1991 ; Vesikari et al., 1991) .
Cross-hybridization studies and nucleotide sequence analysis of rotavirus strains recovered from neonates with symptomatic and asymptomatic infections have implicated the fourth gene (which encodes the VP4 protein) in virus attenuation (Flores et al., 1986; Gorziglia et al., 1988) . A neutralization assay has also been used to show the distinct nature of the asymptomatic The sequence data reported in this paper have been submitted to GenBank and assigned the following accession numbers: rotavirus strain VE7156, L25265; strain SC2, L25266; strain MtB2, L25267; strain MtA5, 25268. strains . The VP4 protein is a minor constituent of the rotavirus outer capsid and performs a number of biologically important functions. It is responsible for the haemagglutination activity of certain rotaviruses and for restriction of human rotavirus growth in cell culture. It also plays an important role in the virulence of heterologous rotaviruses for mice, induces neutralizing antibodies and is the site for protease activation of infectivity (Kapikian & Chanock, 1990) .
VP4 types have been defined on the basis of neutralization assays or sequence analysis (Gorziglia et al., 1988; Estes & Cohen, 1989) . Comparison of the sequences of the fourth gene identified at least five genotypes (P types) among human rotaviruses: P1, associated with symptomatic rotavirus strains of serotypes G1, G3, G4 and G9; P2, associated with symptomatic infections caused by strains of serotype G2 and G12; P3, associated with strains of serotypes G1 to G4 and obtained from newborns with asymptomatic infections; P4 and P5, found in strains K8 (G1) and 69M (G8) respectively, which were recovered from patients with symptomatic infections (Gorziglia et al., 1988; Taniguchi et al., 1989 Taniguchi et al., , 1990 Qian & Green, 1991) . Recently a sixth P genotype was described in the strain HCR3 (G3), isolated from an asymptomatic infant in the Qian & Green (1991) . CP, connecting peptide; FP, putative fusion peptide. Amino acid positions are indicated.
U.S.A. (Li et al., 1993) and rotavirus strains bearing a P genotype related to that of the bovine strain B223 were described in asymptomatic children in India (Gentsch et al., 1993; Das et al., 1993) . The VP4 classification system described above was suggested by Gorziglia et al. (1988) and adopted by Gentsch et al. (1992) for the PCR Ptyping assay of human rotavirus. Since the strains in this report were characterized by PCR and sequence analysis, the same system was used. Rotavirus P3 strains are usually recovered from neonates with asymptomatic infections. Nevertheless, several P3 strains have been isolated from children with gastroenteritis in recent epidemiological surveys. In a study in Latin America and Europe, 18 cases of P3associated diarrhoea were identified, including four cases from an outbreak among neonates (Steele et al., 1993a) . In another study in South Africa, P3 strains were recovered from three neonates and an infant with diarrhoea (Steele et al., 1993 b) . Other cases of P3 viruses associated with symptomatic infections have been reported in children in Venezuela, Bangladesh and Australia (Larralde & Flores, 1990; Bern et al., 1992; Coulson, 1993) . In a survey of P types in the U.S.A., we identified two P3 rotavirus strains, SC2 (G2) and VE7156 (GI) from newborns 11 and 17 days old respectively, with severe diarrhoea . Three P3 (G3) strains, #1949, #1607 and #1608, recovered from nonhospitalized children (6 months, 2 and 4 years old) with diarrhoea in S~o Paulo, Brazil were also analysed. For comparison, we included two 'nursery' strains obtained from an epidemiological survey in two hospitals in Paris, France, in which 157 newborns were found to be shedding rotavirus in the absence of any clinical symptoms. A single distinct electropherotype was identified in each hospital. The two representative asymptomatic strains, MtA5 and MtB2, were recovered from a 3day-old newborn at Maternit~ Sainte F~licit6 in 1985 and a 6-day-old newborn at H6pital Lariboisi~re in 1984, respectively. They were adapted to growth in cell culture at H6pital d'Enfants Armand-Trousseau in Paris, and identified as P3 strains by the PCR P-typing assay (V. Gouvea, unpublished results).
Proteolytic cleavage divides rotavirus VP4 into two peptide fragments, designated VP8* and VP5*. Antigenic analyses have demonstrated that the VP8* subunit bears the major epitopes responsible for serotype specificity, whereas the VP5* subunit is more closely related to cross-neutralization epitopes (Estes & Cohen, 1989 ). In the present study we have sequenced the VP8* segment of the P3 strains described above to confirm whether or not these strains all belong to the same P genotype. Moreover, because the VP4 gene has been implicated in virulence, we analysed selected portions of this gene in an attempt to define virulence markers. For this purpose, we sequenced regions in the VP4 gene in which the amino acid sequence of asymptomatic P3 strains are highly conserved but divergent from (non-P3) symptomatic strains (Fig. 1) .
The two asymptomatic strains from Paris (MtA5 and MtB2) and one symptomatic strain from Philadelphia (SC2) were adapted to growth in cell culture in their respective countries of origin. The symptomatic strains VE7156 from Buffalo, N.Y. and #1949, #1607 and #1608 from S~o Paulo were stool specimens. Portions of the fourth genes of each strain were sequenced from PCR products obtained directly from stool samples or cell culture fluids. Rotavirus dsRNA was extracted from stool and cell culture samples as described by . The region encoding VP8* and the connecting peptide were amplified by PCR using the primer pair Con2-Con3 described by Gentsch et al. (1992) . For amplification of the regions located in VP5*, primers were designed on the basis of the sequence of rotavirus strain 1076 (GenBank; accession number M88480). For the region located between amino acids 380 and 383, and for the putative fusion peptide, the primers (5' to 3') were GCTAATTATCAGTACA-ATTAC (sense; nucleotide positions 901 to 921) and GTACAATCCTGACACACGTGT (antisense; positions 1330 to 1350). For the region between amino acids 742 and 748 the primers were GAAGAAGTACCAT-TTGACGTA (sense; nucleotides 2101 to 2121) and CTCTCACAGTCTACATTGCAG (antisense; positions 2320 to 2340), and for the region between amino acids 578 and 608 the primers were CTGCTTCA-TCAGTTTCCAGAAGT (sense; positions 1718 to 1740) and the same antisense primer used for the second region described above. The PCR was performed as described al. (1992) . The cDNAs generated by PCR were purified with Ultrafree-MC filters, according to the manufacturer's instructions (Millipore) and used as templates in the sequencing reactions. In addition to the primers used for PCR amplification, nine primers were used for the sequencing reactions. The nucleotide sequence was determined using the Sequenase Version 2.0 kit (USB) and analysed by computer with the DNASTAR program (DNASTAR). To rule out any possibility of contamination, the PCR and sequencing reactions for each strain were performed separately. The predicted amino acid sequences of VP8*, the connecting peptide and N terminus of VP5* of rotavirus strains VE7156, SC2, MtA5 and MtB2 were compared to those of asymptomatic P3 strains M37, 1076, McN13, ST3 and the recently described (possibly P6) strain HCR3, as well as with symptomatic human strains KU (P1), RV-5 (P2), K8 (P4) and 69M (P5) ( Table 1) . The VP4 amino acid sequence of the porcine rotavirus strain Gottfried (Gott) was included in the comparative analysis because it shows a close similarity to those of the asymptomatic P3 strains (Gorziglia et al., 1990) and had been tentatively classified into the same P genotype group as the P3 strains (Estes & Cohen, 1989) .
The overall results indicated high amino acid identities (~> 92"7%) among the four strains sequenced and the asymptomatic P3 viruses M37, 1076, McN13 and ST3 in the VP8* segment, confirming that they belong to the same P genotype (Table 1) . Nevertheless, we found a T .............   N ............... V ......... I .. region from amino acids 49 to 53, within variable region A, which was shared by strains VE7156, SC2, MtA5 and MtB2, but was highly divergent from the other human P3 strains previously reported and differed from the porcine strain Gott by a single amino acid residue at position 51 (Fig. 2) . Because of this result we amplified and partially sequenced the VP8* region of three symptomatic P3 strains obtained from Brazil. The Brazilian strains (#1949, #1607 and #1608) showed total identity in region A with the two symptomatic and two Short communication asymptomatic P3 strains sequenced in this study (results not shown). Two other variable regions in VP8* (regions B and C) and the connecting peptide were highly conserved among all human P3 strains reported here or previously reported by Gorziglia et al. (1988) (Fig. 2) .
Analysis of three variable regions, D and F (Gorziglia et al., 1988 ) and E (Qian & Green, 1991) in VP5, also showed high similarities among both symptomatic and asymptomatic P3 strains ( Table 2 ). The region encoding the putative fusion peptide was also sequenced, since it bears strain-specific epitopes (Estes & Cohen, 1989; Kobayashi et al., 1991) . Our results indicated that this segment was highly conserved between symptomatic and asymptomatic P3 strains ( Table 2) .
The genetic conservation of the VP4 gene of P3 strains has been demonstrated by RNA-RNA hybridization and sequence analysis (Flores et al., 1986; Gorziglia et al., 1988) and our findings are consistent with these data. As expected, the highest identities were between strains from the same country, for example strains MtA5 and MtB2 from France (99-7 %) and VE7156 and SC2 from the U.S.A. (97.2%). Although isolated 10 years apart, the VP8* sequences of the strains from the U.S.A. were still highly conserved. Human rotavirus bearing P3 and any of the four major human G specificities (G1 to G4) have been found in newborns with asymptomatic infections in four different countries (Hoshino et al., 1985) . In the present study, we analysed two P3 strains recovered from newborns with asymptomatic infections in Paris bearing G3 (MtA5) and G4 (MtB2) specificities. The extremely high identity of their VP8* sequences reinforces the hypothesis that these strains are likely to be natural reassortants bearing a unique 'nursery' P3 VP4 gene and the VP7 gene of local 'community' strains (Flores et al., 1986; . Gorziglia et al. (1988) noticed five regions in VP4 in which a sequence was conserved among asymptomatic strains and a different sequence is conserved among symptomatic strains (regions A, B, C, D and F; Fig. 1 ). Qian & Green (1991) described yet another such region (region E) located between amino acids 578 and 608. The connecting and putative fusion peptides also differ significantly between symptomatic and asymptomatic viruses. We sequenced all of these regions and could not identify any amino acid(s) that could be associated with virulence. Moreover, Gorziglia et al. (1988) pointed out 91 positions in the amino acid sequence throughout VP4 at which an amino acid was conserved among the virulent strains and a different amino acid was conserved among the avirulent strains. Fifty of those positions are located in the VP4 portion that includes VP8*, the connecting peptide and the N terminus of VP5*. Identity was found in almost all of these positions for the symptomatic and asymptomatic human P3 strains. The only exceptions were the five amino acid changes in variable region A of all P3 strains, and one conserved change at position 23 in strain SC2. The other 41 amino acids are located in the VP5* subunit. Comparison of the amino acid sequence of VP5* of the asymptomatic strains 1076 and HCR3 and symptomatic strains K8 and 69M demonstrated that none of these 41 amino acids were present exclusively in symptomatic or asympto-matic strains. Thus, they are not likely to be related to virulence.
Neonatal rotavirus infections in children are frequently asymptomatic, and well researched epidemiological observations have shown this to be associated with P3 genotype (Bishop et al., 1983; Chrystie et al., 1978; Hoshino et al., 1985; Flores et al., 1986; Perez-Schael et al., 1984; Rodger et al., 1981) . In the present study we report the finding of two new P3 'nursery' strains (MtA5 and MtB2) endemic in French hospitals, adding support to the hypothesis that P3 rotaviruses might be naturally attenuated for newborns. On the other hand, P3 strains have been sporadically recovered from severely ill neonates and older children but no further information on their VP4 sequences is available. In an attempt to identify possible virulence markers, we analysed some P3 strains recovered from children with gastroenteritis during surveys on rotavirus P types in the U.S.A. and Brazil (unpublished results). However, we could not identify any relevant differences between symptomatic and asymptomatic human P3 strains in the regions of VP4 suspected to play a role in virulence. Although the P3 genotype is probably better adapted to neonatal physiology, infection with this genotype does not appear, in itself, to guarantee attenuation of symptoms. P3 strains do not exclusively infect newborns, as we isolated several from children who were 6 months to 4 years old. Neither are these strains restricted to nurseries, as we also isolated them from children in a day-care centre. Furthermore, other P genotypes (strains HCR3, ll6E and I321) have been found to infect newborn children without causing symptoms (Li et al., 1993; Gentsch et al., 1993; Das et al., 1993) . It is possible that attentuation may be due to another gene, a combination of genes, or most probably an interaction between the virus strain and host factors. Several host factors have been implicated in the attenuation of rotavirus infection in the newborn: the presence of antibody to rotavirus, trypsin inhibitors and cellular components in breast milk, non-immunoglobulin antiviral activity, the unique intestinal bacterial flora of neonates, and the physiological immaturity of the gut (reviewed by Haffejee, 1991) . A correlation between these factors and protection against disease needs to be investigated more fully. Although apparently rare, the involvement of P3 strains in severe neonatal dehydrating diarrhoea raises concerns about the safety of a P3 or M37-1ike vaccine for newborn children.
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